Background Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but non-invasive tools for risk stratification are limited. The C-reactive protein–triglyceride–glucose (CTI) index integrates metabolic and inflammatory pathways, but its value in MASLD is unclear. Methods We examined the association between CTI and obstructive coronary artery disease (CAD) in MASLD patients who underwent coronary computed tomography angiography. Machine-learning-assisted feature selection was used to assess the relative stability of CTI among candidate clinical variables, and multivariable logistic regression was used to evaluate its independent association with obstructive CAD. Discriminative performance was assessed using ROC curves, calibration analysis, clinical impact analysis, and restricted cubic spline analysis, with sex-stratified and sensitivity analyses. The prognostic relevance of CTI for all-cause and cardiovascular mortality was further evaluated in a population-based NHANES MASLD cohort. Results Higher CTI quartiles correlated with greater metabolic burden and CAD prevalence (P < 0.001). CTI was independently associated with obstructive CAD (OR = 1.68, 95% CI 1.33–2.12), with a graded association across quartiles. CTI showed moderate apparent discrimination for obstructive CAD, with higher AUCs than FIB-4, TyG-BMI, and TyG in the overall, male, and female populations. In the NHANES cohort, elevated CTI was associated with increased risks of all-cause and cardiovascular mortality, with the association for cardiovascular mortality being more evident in men than in women after full adjustment. Conclusion CTI was independently associated with CCTA-defined obstructive CAD in a high-risk MASLD cohort and showed prognostic relevance for long-term mortality in a population-based MASLD cohort.
MASLD significantly increases the risk of cardiovascular events and all-cause mortality (ACM). The impact of the C-reactive protein-triglyceride-glucose index (CTI) and its derivatives on mortality in the MASLD population remains unclear. This study aimed to investigate their associations with mortality in the MA...
Guang-Jie Tu, Hang Zhai, Jun-Ming Xu et al.· BMC Cardiovascular Disorders· 0 citations
In a cohort without known CAD, baseline TyG independently predicts long-term MACE in T2DM, and this simple, widely available metabolic marker may enhance cardiovascular risk stratification and MACE primary prevention strategies.
Yuval Avidan, D. Halon, Amir Yahav et al.· Current problems in cardiolo...· 0 citations
A higher CHG index was associated with a higher Gensini score in patients with CAD, suggesting that this simple and inexpensive metabolic marker may provide complementary information for assessing coronary atherosclerotic burden.
Jia-Yu Zhang, Hong-Xin Dong, Sheng Lei et al.· Frontiers in Nutrition· 0 citations
Background/Objectives: Lipid-derived and lymphocyte-based inflammatory indices (LBIIs) are studied in coronary artery disease (CAD), but their relationship with angiographic burden in patients aged ≤45 years with non-ST-elevation myocardial infarction (NSTEMI) remains unclear. We evaluated clinical, laboratory, lipid-d...
Şükriye Uslu, G. M. Yılmaz Öztekin, Muhammed Rıdvan Ersoysal et al.· Journal of Clinical Medicine· 0 citations
Objective To investigate the associations of composite glucose–lipid metabolic indices and echocardiographic parameters with coronary heart disease (CHD), and to determine whether integrating metabolic burden and cardiac function could improve pre-angiographic risk stratification and reflect coronary lesion severity. M...
Xing-Xing Che, Meng-Ting An, Wen-Kai Liu et al.· Frontiers in Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.